• LXRP CEO Chris Bunka explained in the interview that proprietary technology can save 60,000 lives annually if consumption habits of even one percent of smokers worldwide change
• CEO Clips videos are featured on business sites including BNN Bloomberg, Thomson Reuters, Yahoo! Finance and Stockhouse.com
• Bunka went on to described LXRP’s growing patent portfolio and noted that ingesting rather than inhaling, using DehydraTECH technology, could be a lifesaver

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka sought to raise awareness of LXRP in the financial community as he appeared, March 23­­-24, on CEO Clips via YouTube. In the video, Bunka explained the benefits of DehydraTECH technology, noting that ingesting drugs and molecules is healthier than inhaling them, and doing so could be a lifesaver for smokers around the world.

CEO Clips boasts the largest library of publicly traded CEO videos broadcast in the United States and Canada on national TV and on 15 business sites, such as BNN Bloomberg, Yahoo! Finance, Thomson Reuters, Stockhouse.com and others.

“Lexaria Bioscience has the actual opportunity of changing the world,” Bunka said in the video (http://ibn.fm/keHWB). “We can do it through saving lives, making health improvements for any number of people who are injecting any number of drugs or molecules like pain relief, cannabinoids or nicotine. Everybody knows that smoking is not healthy. Our technology allows for the delivery of drug molecules like cannabinoids or nicotine through ingestible means, things that you swallow. It could be a pill, a syrup or a cup of coffee. That technology, which is called DehydraTECH, is optimized to carry that drug across the intestinal wall and get more of it to your bloodstream more quickly than it otherwise could.”

He added that LXRP has tested DehydraTECH in vitro and in vivo in human clinical studies. Bunka further explained, “We actually have seven different R&D projects that we are launching in the first half of 2019. We’re also continuing to work on our patent portfolio. We have ten patents granted already and over 50 more that are pending. If we are able to help change the consumption habits of even one percent of the global marketplace who smoke we could save 60,000 lives a year.”

Based in British Columbia, Canada, LXRP is a biotechnology company and drug-delivery platform innovator, and DehydraTECH is the company’s proprietary absorption technology platform. LXRP holds a patent for oral delivery of all cannabinoids and has a growing IP portfolio that includes 10 patents granted in the United States and Australia, and more than 50 patent applications worldwide across 10 patent families.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Job growth in cannabis industry rose 44 percent in 2018, outpacing other sectors in job market
• Subsidiary BudHire uniquely positioned to capitalize on growing need for outsourced personnel solutions
• Legal cannabis spending worldwide expected to increase from $20.1 billion in 2018 to $43.3 billion in 2022 and $63.5 billion in 2024

Cannabis Strategic Ventures Inc. (OTC: NUGS), a Los Angeles-based cannabis firm, is moving swiftly to secure footholds in various sectors of the booming cannabis industry. Economists note that job creation in the cannabis industry is beginning to roll out massive numbers on both the recreational and medicinal sides, with 64,389 new positions added in 2018. That’s a 44 percent increase on the previous year, making it the fastest-growing job sector in the country right now, as an article in Forbes points out (http://ibn.fm/ImSyx).

Supporting this rapidly growing industry is the prime strategy of Cannabis Strategic Ventures. Among the company’s subsidiaries is the aptly-named BudHire, an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations. Research conducted by Glassdoor shows that cannabis job openings are increasing rapidly, with 1,512 open in the U.S. during December 2018 – a 76 percent increase over the same period in the previous year. More than 50 percent of those jobs are for professional and technical workers from a variety of fields, Glassdoor found (http://ibn.fm/BsmkE).

Cannabis Strategic Ventures and BudHire utilize a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire brand, Cannabis Strategic Ventures offers temporary, seasonal and permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry (http://ibn.fm/3mqL3).

The legal status of cannabis continues to evolve, with several legislative bodies in numerous U.S. states taking up the issue. In recent days, legislators in New Jersey shelved a bill that would legalize adult-use cannabis, while a legislative law committee in Connecticut approved a plan that would establish a framework for the sale of cannabis products (http://ibn.fm/qAFHS). Legislators in New York are still discussing the issue. So far, 10 U.S. states have now legalized the recreational use of cannabis, while another 34 have approved its use for medicinal purposes.

For Cannabis Strategic Ventures, staying ahead of the curve includes cultivating and partnering with category leaders in the cannabis and CBD (cannabidiol) markets. The company’s portfolio of subsidiaries also includes:

• The Asher House Wellness, a producer of high-quality ingestible CBD oil products tailored for pet consumption;
• Fitamins, a producer of sports performance products derived from phytocannabinoids, hyaluronic acid and MSM;
• LYXR, a line of luxury skin care products derived from hemp CBD and other dynamic ingredients with hydrating, regenerating and anti-aging properties;
• Halo Filters, a developer of industry-leading filters made of patent-pending materials that reduce harmful chemicals and protects the lungs; and
• Pure Applied Sciences Inc., whose offerings under the Pure Organix brand include a line of high-quality, organic, cGMP- and FDA-compliant cannabis oils.

Recently, Cannabis Strategic Ventures announced that it has secured a $3 million investment to fast-track corporate expansion. The company obtained this investment from Triton Funds subsequent to a forthcoming S1 registration statement (http://ibn.fm/73h9c). This financing is expected to enable Cannabis Strategic Ventures to hasten its business priorities associated with cannabis cultivation operations in California and the expansion of existing portfolio brands.

For more information, visit the company’s website at www.CannabisStrategic.com

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

• The company estimated unaudited revenue of $8.4 million for the fiscal period ended December 31, 2018
• The figure represents a 684 percent increase over FY2017 revenues
• Plus Products was ranked as the number one edibles brand in California during the third quarter of 2018

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading edibles manufacturer with sales exclusively in California, recently provided its unaudited revenue estimate for the fiscal period ended December 31, 2018. This revenue estimate indicates that the company witnessed impressive growth during the 12-month period (http://ibn.fm/w7DZc).

The company estimates that its unaudited revenue for the period totaled $8.4 million. This figure represents a 684 percent increase over its FY2017 revenues of $1.1 million (http://ibn.fm/funFW). Fourth-quarter revenue estimates for 2018 were $3.4 million, marking a nearly 32 percent increase over the third quarter of 2018. In addition, the company’s retail sales in the fourth quarter were $10.53 million – nearly 40 percent more than the third quarter of 2018.

Most significantly, Plus Products was ranked as the top edibles brand in California during the third quarter of 2018, according to retail sales data gathered by both BDS Analytics and Headset (http://ibn.fm/aYRVT).

The company seeks to support consumers in pursuing a healthy and active lifestyle by providing premium-quality edibles products. Indeed, according to BDS Analytics, PLUS Uplift and PLUS Restore retained their positions as the top two best-selling edibles products in California.

The company’s PLUS Uplift Sour Watermelon gummy secured (http://ibn.fm/9koi7) the industry’s position as the “top selling branded product of the more than 20,000 products sold across all cannabis categories in California in 2018.” Similarly, the company’s PLUS Blackberry & Lemon Gummy was the second-best-selling branded product across all categories in California. This included flower, vaporizers, edibles and topicals (http://ibn.fm/aiPHy).

This steady revenue growth and noteworthy product acclaim are made all the more remarkable for Plus Products when accounting for California’s recent market trends. In 2018, there were 17 percent less legal sales in California cannabis than in 2017. Though the California cannabis market was often impeded by “licensing challenges, regulatory changes, taxes and new testing, and labelling and packaging requirements,” PLUS maintained its steady growth. Due to its increase in unit sales, PLUS has improved its edibles market position from number four to number one in retail value of sales (http://ibn.fm/vyWLJ).

In a news release (http://ibn.fm/YzzzI), Plus Products CEO Jake Heimark said, “We are grateful to the California consumers who have made PLUS the leading cannabis product in California, the largest and most competitive cannabis product in the world.” He noted that the company is intent on broadening its geographic reach while pledging to consistently offer its customers products that deliver “consistent experiences in delicious formats.”

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• Wildflower Brands is advancing its goal of becoming a global health and wellness leader by inking a delivery fulfillment agreement with nationally prominent cannabis educator HelloMD
• Wildflower has been investing in building its cannabis licenses, products and services in California, as well as in online outlets and throughout the United States
• The company’s online store sales have grown more than 300 percent since January 2018, with yearly revenues topping $1 million

Plant-based health and wellness brand builder Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) recently announced a delivery fulfillment agreement with medical cannabis education outlet HelloMD, expanding the monetization of Wildflower’s California operations.

WLDFF’s brands, Wildflower Wellness, King Extracts and Exclusive, are the vehicles by which the company is working to become a global wellness leader. Wildflower Wellness is focused on delivering its lineup of full-spectrum cannabidiol (CBD)-infused products through the media of CBD vaporizers, capsules, tinctures and soaps. King Extracts focuses on delivery systems that comply with California’s regulations and on related technologies, including concentrates made from CO2 extractions with proprietary terpenes blended in for flavor. Exclusive dispenses high-quality cannabis in Los Angeles, working closely with select hospital oncology departments and community programs.

The delivery agreement with HelloMD establishes a working partnership with a prominent national platform for cannabis doctors, consumers and brands. Through joint ventures or white-label solutions, HelloMD partners leverage its platform to attract, nurture, convert and retain patient demand for medical cannabis.

“HelloMD has been a significant wholesale customer and provides us with a great position as a premium health and wellness brand,” Wildflower CEO William MacLean stated in a news release about the agreement (http://ibn.fm/vGXgD). “I am very happy to see our relationship grow to further bring quality information and products to consumers with conditions that benefit from plant-based healing in a timely manner.”

California is the world’s largest cannabis market, although Canada is expected to eventually overtake the state during the next decade thanks to its nationwide drive toward full legalization of cannabis use (http://ibn.fm/AEKuF).

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail, but the company’s distribution network extends beyond California to more than 200 retailers in the state of Washington and more than 20 additional retailers in New York City. Between the two coasts, distribution in other U.S. markets includes over 80 wellness and health care practitioners that boost Wildflower’s total distribution to over 300 stores nationwide.

The company reports that its direct-to-consumer online store sales have seen growth of more than 300 percent since January 2018, with yearly revenues topping $1 million. Revenues have increased for nine reporting quarters without a break in the trend.

WLDFF recently completed a private placement of $1.8 million to fund the build out of the company’s manufacturing capability in Washington in response to the growing demand for its products, as well as for general working capital to further Wildflower’s interests.

For more information, visit the company’s website at www.WildflowerBrands.co

NOTE TO INVESTORS: The latest news and updates relating to WLDFF are available in the company’s newsroom at http://ibn.fm/WLDFF

• Kontrol Energy and Toyota Tsusho Canada recently announced a strategic partnership that will result in a smart factory tech solution based on Kontrol’s IoT hardware and software
• In addition, Kontrol announced plans to be offer innovative solutions in the cannabis industry for odor and emission control

Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8), a smart energy technology company, is planning to expand its smart solutions and introduce new developments in various verticals during 2019. At the end of March 2019, the company announced a strategic partnership, followed by an early April announcement that it plans to expand its odor and emission solutions for the cannabis industry.

Kontrol Energy and Toyota Tsusho Canada announced a smart factory strategic partnership on March 25, 2019 (http://ibn.fm/jz1TM). The smart factory tech solution will bring together Kontrol’s internet of things (IoT) hardware and software with Toyota Tsusho Canada’s existing production. The aim of the partnership is to ensure the operation of improvement platforms and power generation/HVAC products for the North American automobile and OEM parts industries.

“We selected Kontrol as our partner in the Smart Factory initiatives due to their extensive experience in developing technology solutions which integrate IoT hardware and software to create a smart environment to optimize operating efficiencies. This agreement with Kontrol will enable us to deliver production and energy efficiencies and give our customers a technology solution to drive down their costs and gain a competitive advantage,” Toyota Tsusho Canada President Hidetoshi Tada said in a news release.

On April 1, Kontrol made an additional announcement, this time targeting innovation in the cannabis industry (http://ibn.fm/tEpUM). The company announced an expansion of its solutions aimed at addressing increasing regulations from local and provincial governments pertaining to cannabis growing and production.

These regulations are meant to deal with emissions and odors in various industry sectors across Canada. As the cannabis industry became legalized, the need for odor control solutions increased. Ensuring compliance is something with which many businesses aren’t prepared to deal, Kontrol Energy CEO Paul Ghezzi said.

ORTECH, Kontrol’s operating subsidiary, has more than 40 years of experience in dealing with emissions and odors in various industries. The company offers turn-key services tailored to the needs of respective businesses and scientifically aimed at identifying, measuring and mitigating VOCs.

Through such developments, Kontrol will be positioned to expand its market share and establish a solid position in the growing Canadian legal cannabis market.

While 2019 is just getting started, the year has proven to be very fruitful for Kontrol so far. The company already secured its third contract with a licensed Ontario cultivator for emission and odor control.

Kontrol’s growth was further strengthened through a series of acquisitions. Since its inception, the company has finalized six acquisitions that include Kontrol Technologies, Log-One Ltd., ORTECH Consulting Inc., Efficiency Engineering Inc., MCW Dimax Ltd. and CEM Specialties Inc. A seventh possible acquisition was announced on March 14, 2019. Based on these milestones, Kontrol has accomplished amazing revenue growth, Ghezzi noted.

For more information, visit the company’s website at www.KontrolEnergy.com

NOTE TO INVESTORS: The latest news and updates relating to KNRLF are available in the company’s newsroom at http://ibn.fm/KNRLF

• Youngevity International is a multi-faceted lifestyle company that is rapidly increasing its hemp-based cannabidiol oil production for varied industries
• Youngevity subsidiary Khrysos Global has inked a contract to provide 50 percent of its capacity for 99 percent pure cannabidiol oil, with additional contracts anticipated
• Cannabidiol-infused beverages are gaining traction in the emerging cannabis industry, with anticipated revenue potential between $900 million and $4.4 billion by 2024
• Youngevity’s HempFX and CLR Roasters brands will begin selling cannabidiol-infused coffees next month, and the company is working on another cannabidiol drink under an agreement with Icelandic Glacial bottled water

Multi-faceted and flexibly-oriented lifestyle company Youngevity International Inc. (NASDAQ: YGYI) is expanding its operations in the cannabis industry following the announcement that its subsidiary, Khrysos Global, has entered a contract to produce 99 percent pure cannabidiol oil from hemp that’s free of the psychedelic tetrahydrocannabinol (THC) found in cannabis’ marijuana strains.

The one-year supply and processing agreement is expected to begin with shipments this month and continue in equal amounts through March 2020, amounting to what Khrysos President Dwayne Dundore described as 50 percent of the company’s production capacity utilizing its supercritical CO2 technology (http://ibn.fm/FH1l7). Contracts for the remainder of the company’s production capacity are expected to be executed during “the next few months,” he added.

“We are excited to reach the revenue stage for the end to end processing component of our business model,” Dundore stated in the news release. “Due to customer demand we are implementing our plan of increasing our end to end processing capabilities by 10 times in Q3 of this year providing estimated annual revenue potential in excess of $220 million at current market prices.”

Youngevity acquired Khrysos Global in February (http://ibn.fm/W9aFh). Khrysos is a Florida-based manufacturer of hemp-based CBD extraction equipment and the operator of INX Labs, which provides environmental analysis, fuel and feedstock analysis and mined rare earth analysis (http://ibn.fm/m9C1b).

The Khrysos acquisition accelerated YGYI’s activity in the hemp-based CBD industry, providing systems that could be immediately implemented in YGYI’s line of HempFX products and in offtake agreements that the company has through its existing business relationships, according to CEO and Chairman Steve Wallach.

“We see this as providing not only immense value to our company, but also to our investors since we’ll be selling not just the extraction systems, but also generating income servicing and operating these systems via a rental model,” Wallach added.

Youngevity’s virtual Main Street stable of products and services allows the direct marketer to appeal to consumers in the top eight revenued retail categories, including health and nutrition, home and family, food and beverage (including coffee), spa and beauty, fashion, essential oils, photo and innovative services. The company’s hybrid direct sales business model values e-commerce and social selling and is particularly serviceable to the cruise line industry.

In January, the company announced an exclusive agreement with Icelandic Glacial bottled water that’s anticipated to lead to the development of a ready-to-drink CBD product. In March, the company added plans to launch CBD-infused coffees, which are expected to begin with rollout under Youngevity’s HempFX brand early next month, followed by a second product under its CLR Roasters brand later in the month.

An estimated 64 percent of American adults drink coffee on a regular basis, according to a 2018 study commissioned by the National Coffee Association (NCA) (http://ibn.fm/IM8I2), and analysts at Deloitte foresee the potential revenues for the overarching cannabis-infused beverages market at somewhere between $900 million and $4.4 billion by 2024 (http://ibn.fm/dAA7x), highlighting the expanding potential for the company.

For more information, visit the company’s website at www.Youngevity.com

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://ibn.fm/YGYI

• Conference call and webcast set to begin at 5 p.m. ET on Thursday, April 4
• A Q&A session will follow the event, providing a more in-depth analysis of the results
• A replay of the call will be available for two weeks, while the webcast will be uploaded to the company’s website

Canadian licensed producer of premium cannabis products The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) is releasing its fourth quarter 2018 results on Thursday, April 4, 2019, as the company announced in a press release (http://ibn.fm/JvwYM). The results will be released via a conference call and webcast after the close of the financial markets.

The conference call and webcast, set to begin at 5 p.m. Eastern Time, will review the company’s Q4 results in depth and will be followed by a question-and-answer session for additional clarifications. Interested parties will be able to access the call via toll-free number 1-877-705-6003, or via 1-201-493-6725 for overseas callers. The webcast can be accessed at www.Flowr.ca/Investors

A telephonic replay of the call will be made available later today through Thursday, April 18, by dialing toll free at 1-844-512-2921 or toll/international at 1-412-317-6671 and entering replay PIN 13689126. The webcast will be uploaded to the company’s website.

Flowr, through its subsidiaries, holds a cannabis production and sales license granted by Health Canada. With a head office in Toronto and a production facility in Kelowna, British Columbia, Flowr builds and operates large-scale, GMP-designed cultivation facilities. Flowr’s investment in research and development, along with its sense of craftsmanship and spirit of innovation, is expected to enable it to provide premium-quality cannabis that appeals to the adult-use recreational market and addresses specific patient needs in the medicinal market.

For more information, visit the company’s website at www.Flowr.ca

NOTE TO INVESTORS: The latest news and updates relating to FLPWF are available in the company’s newsroom at http://ibn.fm/FLWPF

• Cowen sees CBD “gaining traction” with independent pharmacies, which find the high margins and differentiation from larger chains offered by CBD oils attractive
• ETST is widening the market for its CBD products to pharmacies, dispensaries, health care practitioners and others under new distribution agreements
• Report projects that the cannabis market will reach $16 billion by 2025 and cannabis-based products will reach 10 percent of U.S. adults

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is expanding its full-spectrum CBD product distribution to wider markets, including pharmacies. Cowen & Co. research finds that independent pharmacies like the high margins and differentiation from larger chains offered by CBD oils (http://ibn.fm/cmABH).

“CBD products appear to be gaining traction with independent pharmacies, many of whom are already selling or planning to sell CBD oils,” analyst Charles Rhyee wrote in the Cowen report titled ‘Cowen’s Collective View of CBD’. “Independent pharmacies likely find the high-margin profile of CBD oils attractive, which we suspect is similar to those of more traditional over-the-counter drugs, as well as the differentiation it affords independents relative to larger chain pharmacies.”

The Cowen analysis projects that CBD products in the United States will hit $16 billion by 2025 and reach 10 percent of U.S. adults. Cowen found in a survey of 2,500 adults that 6.9 percent of Americans already use CBD as a supplement (http://ibn.fm/fej71). Rhyee added that independent pharmacies like the exclusivity that CBD oils offer them in their competition with larger chains.

ETST has reached agreements with CannaBiz and Desert Sun Distribution to sell its line of CBD products, including full-spectrum cannabinoid oil, to pharmacies, chiropractors, dispensaries, health care practitioners, athletic clubs and clinics throughout the United States, thus widening its penetration into this market (http://ibn.fm/Brec2). In a news release, ETST Chief Sales Officer David Burbash said, “We see tremendous synergy between our CBD line and the healthcare practitioner and pharmacy spaces.”

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• Company has achieved record-breaking growth, with sales revenues topping $64 million
• SHRV benefits from a diversified platform
• A strategic name change, in addition to the appointment of a multilingual chief marketing officer, sets the stage for international expansion

Sharing Services Global Corporation (OTCQB: SHRV), formerly known as Sharing Services Inc., has seen a record-breaking pace of growth. Success is credited to SHRV’s Elepreneurs and their ability to execute the company’s mission, which is to change the direct-selling industry with best in-class products and services. Elepreneurs are independent contractors who share Elevacity products and invite others to join them on the Elepreneur team. Since its product launches of December 2017, the company has reported sales revenues of more than $64 million (http://ibn.fm/BfVK2). Operating under two divisions, Elevacity Global LLC and Elepreneur LLC, SHRV owns significant stakes in a variety of companies within the direct-selling industry.

SHRV is working to change the direct-selling industry by focusing on mentorship and securing a vested interest in the success of several direct-selling businesses. The company takes a percentage of ownership in different firms across various sectors. While other direct-selling businesses create a niche with one product line, SHRV benefits from a diversified platform.

Based in Plano, Texas, SHRV plans to expand globally. The company’s 10,000-square-foot facility in Plano provides room for expansion and space for a growing customer service department, product fulfillment operations, opportunity and training rooms, a video production suite and more. However, the company’s goals reach far beyond Plano, or even Texas. Implementation for expansion is expected to build on the same strategy that has worked so well for Sharing Services to this point.

The company’s recent name change, from Sharing Service Inc. to Sharing Services Global Corporation, is part of a larger vision for international expansion. The company has eyes on expansion into Canada, Mexico, Asia and Europe. On January 9, 2019, SHRV announced Clare Holbrook as the new chief marketing officer for its Elepreneur LLC subsidiary. The announcement (http://ibn.fm/2C4ho) describes Holbrook as a “creative, multilingual marketing leader who leverages hands-on experience in diverse global markets to help create integrated marketing and sales strategies globally.” Her addition to the team is part of the company’s strategic international expansion.

“We’re kind of under the radar right now. A lot of people don’t know about us,” SHRV CEO John “JT” Thatch stated in a news release (http://ibn.fm/Qq808). “[But] they soon will.”

For more information, visit the company’s website at www.SHRVInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRV are available in the company’s newsroom at http://ibn.fm/SHRV

• Multi-year extraction services agreement with Valens GroWorks Corp. expected to accelerate TGOD’s Canadian hemp strategy and market entry
• TGOD is committed to producing premium, certified organic, consumer-preferred products
• Production strategy calls for 80,000 kg of cultivation by end of 2019

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is moving quickly to take advantage of Canada’s nascent legal cannabis market, which is expected to include CBD-infused products by October 2019. TGOD’s recently announced entry into a multiyear extraction services contract with Valens GroWorks Corp. (CSE: VGW) (OTCQB: VGWCF) underscores the company’s focus on meeting a growing need to furnish high-quality, premium organic cannabis products to Canadian consumers, according to a news release (http://ibn.fm/92NET).

“The ability to partner with skilled and specialized extraction operators such as Valens will add significant bench strength to TGOD’s already robust extraction capabilities in Canada, Poland and Jamaica,” Brian Athaide, director and CEO of TGOD, stated in a news release. “We believe the importance of high-quality cannabis oils will continue to greatly increase as patients and consumers look for safer and healthier delivery methods.”

The agreement with Valens, a licensed provider of cannabis products and services specializing in various proprietary extraction, distillation, cannabinoid isolation and purification technologies, will accelerate TGOD’s Canadian hemp strategy and allow for early market entry of TGOD’s organic hemp-derived CBD product lines within the coming months. Under the terms of the initial two-year agreement, Valens will process, extract and purify TGOD’s cannabis and hemp biomass under conditions specified by TGOD, as demanded by final product manufacturing and formulation requirements.

“We are excited to work with TGOD, Canada’s premier certified organic producer,” Tyler Robson, CEO of Valens, added in the release. “Organic resonates with consumers, and Valens looks forward to helping accelerate TGOD’s time to market with the launch of its hemp-derived CBD product line in the coming months.”

Approximately 76 percent of Canadians responding to a recent national cannabis survey prepared by Statistics Canada identified quality and safety as their main concerns when choosing where to purchase cannabis (http://ibn.fm/FsWkI). TGOD cannabis is grown in soil, without synthetic fertilizers, herbicides or pesticides; is never irradiated; and has been certified organic by Pro-Cert Organic Systems Ltd., one of North America’s foremost certification bodies and the second certification body to endorse TGOD’s organic process at its Hamilton, Ontario, facility (http://ibn.fm/DvL18).

TGOD will supply Valens with significant quantities of cannabis and hemp, and Valens will provide extraction purification services processing the cannabis and hemp into premium quality resins and distillates. TGOD intends to use the concentrated cannabinoid resins and distillates to produce oils, sprays and capsules, as well as oils for vaporization and future edible, beverage and topical products. TGOD has been working closely with Valens to help expedite the pathway to organic certification for Valens organic processing methodologies. Upon certification, TGOD will have exclusive access to services provided by Valens for certified organic extraction processing for a period of one year.

The demand for non-intoxicating, hemp-derived CBD products has been strong and supported through significant patient and consumer research. Being first to market in Canada with organically-certified, hemp-derived CBD products could allow TGOD to capture organic CBD market share, securing future growth in this newly legalized cannabinoid vertical (http://ibn.fm/1yOV1).

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF